Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor

Prostate

Volumn 52, Issue 1, 2002, Pages 59-68

  Harper, Maureen E ^a   Goddard, Lindy ^a   Glynne Jones, Eve ^a   Assender, Jean ^a   Dutkowski, Carol M ^a   Barrow, Denise ^a   Dewhurst, Odette L ^a   Wakeling, Alan E ^b   Nicholson, Robert I ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

EGF receptor; MAPK; Prostate cell lines; Tyrosine kinase inhibitor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL CYCLE; CELL LINE; CELL MEMBRANE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL COUNT; CELL CYCLE; CELL DIVISION; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0036604065     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10069     Document Type: Article

References (31)

1. Hormonal treatment of advanced disease: Some newer aspects
2. Targeting signal transduction for disease therapy
3. Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours
4. An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumours
5. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue
6. Secretion of epidermal growth factor and related peptides by the prostate cell line DU-145
7. The role of transforming growth factor-α in human prostate cancer cell growth
8. Signal transduction of receptors with tyrosine kinase activity
9. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signalling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation
10. KIp1 and induces G1 arrest in prostatic cancer cell line DU145
11. Tyrosine kinase inhibitor as a novel signal transduction and antiproliferative agent: Prostate cancer
12. New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145
13. Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines
14. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells
15. Weiss SJ: Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells
16. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton
17. Tamoxifen, 17β-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin
18. Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells
19. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
20. Epidermal growth factor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif
21. Association of p120 ras GAP with endocytic components and colocalization with epidermal growth factor (EGF) receptor in response to EGF stimulation
22. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives
23. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
24. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors
25. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
26. Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence
27. Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer
28. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells
29. Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumour necrosis factor alpha
30. Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3
31. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: Identification of divergent growth regulatory pathways